Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 823 of 6351
-
Tiny radiation seeds take aim at tough pancreatic tumors
Disease control Recruiting nowA unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy shows promise for bile duct cancer
Disease control OngoingA study to assess the safety and efficacy of durvalumab in combination with gemcitabine-based chemotherapy regimens in participants with aBTC.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
A new strategy to lift maternal depression in head start families
Prevention OngoingWithin a research network of Head Start centers in Massachusetts, an efficacy trial of a stepped-care intervention (SCI) to address maternal depression, using intervention components that both prevent depression and help those in major depressive episode (MDE) engage with care, w…
Sponsor: Brown University • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Can a dopamine-blocking drug safely control tourette syndrome over years?
Disease control OngoingThe primary objective of this study is to evaluate the long-term safety and tolerability of ecopipam tablets in children (greater than or equal to \[\>=\] 6 and less than \[\<\] 12 years of age), adolescents (\>=12 and \<18 years of age), and adults (\>=18 years of age) with Tour…
Phase 3 • Sponsor: Emalex Biosciences Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug cocktail aims to stop BRAF colon cancer in its tracks
Disease control OngoingThis phase II/III trial compares the effect of the combination of encorafenib and cetuximab to usual care (patient observation) for reducing the chance of cancer recurrence after standard surgery and chemotherapy in patients with BRAF-mutated stage IIB-III colon cancer. Encorafen…
Phase 2/3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can mindfulness ease chronic pain in the elderly?
Symptom relief CompletedIt has been shown that MBSR could be effective in different types of chronic pain in geriatrics, but more evidence in the interdisciplinary context is needed. This study is conducted to develop and compile a mindfulness-based stress reduction (MBSR) program within a context of p…
Sponsor: Mohammad Soukhtanlou, PhD • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New precision therapy trial aims to match salivary gland cancer patients with the right drug
Disease control Recruiting nowPatients with salivary gland carcinoma were divided into groups according to HER2, NTRK, AR, TROP-2, etc. Patients in different groups were given precision targeted therapy or chemotherapy to evaluate the efficacy (ORR rate) and safety of precision therapy.
Phase 2 • Sponsor: Peking Union Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo shot shows promise for weight loss in chinese adults
Disease control CompletedThis study will look at how well the new medicine CagriSema helps people with excess body weight losing weight compared to a "dummy" medicine and a medicine called semaglutide. Participants will either get CagriSema, a dummy medicine or semaglutide. Which treatment participants g…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could a natural hormone rebuild brains in Alzheimer's?
Disease control OngoingA phase 2, double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of Allopregnanolone as a regenerative therapeutic for Alzheimer's disease.
Phase 2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Freeze and pill combo takes on rare tumors
Disease control Recruiting nowThe primary purpose of this protocol is Systemic therapy with oral study agent, nirogacestat, followed by a single cryoablation procedure.
Phase 2 • Sponsor: Nam Bui • Aim: Disease control
Last updated Jun 26, 2026 14:56 UTC
-
Double immunotherapy before surgery shows promise in early melanoma
Disease control OngoingNeoadjuvant therapy is feasible in stage II melanoma, and the dual inhibition of the distinct LAG-3 and PD-1 checkpoint pathways with relatlimab and nivolumab has a synergistic effect in the tumour microenvironment leading to a pathological response after 2 doses of therapy.
Phase 2 • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for advanced colorectal cancer: experimental combo shows promise
Disease control OngoingThis is a double-blind, randomized, multi-center, II/III study in at least 606 patients with advanced colorectal cancer. The study is being conducted to evaluate the safety of HR070803 combined with oxaliplatin, 5-FU/LV and bevacizumab in phase II and to evaluate the efficacy of …
Phase 2/3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a botox shot in the throat restore swallowing after stroke or Parkinson's?
Disease control Recruiting nowDysphagia in patients with stroke, multiple sclerosis, parkinsonism or dystonia can occur due to relative hypertonia of the cricopharyngeus muscle. In the resting state, muscle is contracted and relaxes only during deglutition. Treatment of dysphagia by injecting botulinum toxin …
Phase 2/3 • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Bladder cancer duo: BCG plus immunotherapy drug shows promise in early trial
Disease control OngoingThe purpose of this study is to assess the safety, tolerability, and efficacy profile of durvalumab + BCG (induction and maintenance) combination therapy in adult United States participants with a histologically confirmed diagnosis of high-risk non-muscle-invasive bladder cancer …
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New COVID-19 vaccine boosters target latest variants in large trial
Vaccine CompletedThe purpose of this clinical protocol is to learn about the safety, tolerability, and immunogenicity of new BNT162b2 RNA-based vaccine candidates targeting new variants of SARS-CoV-2 in healthy people. Substudy A: * This study will evaluate the safety, tolerability, and immunog…
Phase 2/3 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Jun 27, 2026 12:24 UTC
-
Bladder cancer patients get a second chance with their own immune cells
Disease control OngoingThe purpose of the study is to evaluate the feasibility, safety and tolerability of intravesical adoptive cell therapy using TIL (tumor infiltrating lymphocytes) in participants with urothelial cell carcinoma (UCC) non-muscle invasive bladder cancer (NMIBC).
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Radiation zaps lingering brain tumors in lung cancer patients
Disease control OngoingDespite the impressive response rate to third-generation EGFR-TKIs, resistance inevitably develops in most patients. Stereotactic radiotherapy plays a growing role in the management of patients with brain metastasis. This study aims to evaluate the efficacy and safety of stereota…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 26, 2026 17:10 UTC
-
New drug cocktail targets childhood cancers with missing proteins
Disease control OngoingThis research study involves a combination of three drugs given together as a possible treatment for malignant rhabdoid tumor, atypical teratoid rhabdoid tumor, epithelioid sarcoma, chordoma or other tumors that are deficient in one of two possible proteins, either INI-1 (SMARCB1…
Phase 1/2 • Sponsor: Susan Chi, MD • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New strategies boost HIV prevention pills for black women in the south
Prevention CompletedBlack women experience one of the highest incidences of HIV among all subpopulations in the United States, but pre-exposure prophylaxis (PrEP) use among Black cisgender women is very limited. The investigators will implement four strategies (provider training, patient education, …
Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
Could a clotting factor shot save trauma patients from organ failure?
Disease control CompletedUncontrolled hemorrhage within 24 hours after severe trauma is the main cause of death in trauma patients. Hemorrhagic shock may be accompanied by traumatic coagulopathy in the early stages of severe trauma. Among them, the main pathogenesis of traumatic coagulation disorder is t…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC